Criteria to Assess the Predictive and Clinical Utility of Novel Models, Biomarkers, and Tools for Risk of Cardiovascular Disease: A Scientific Statement From the American Heart Association.

Checking your browser before accessing pmc.ncbi.nlm.nih.gov ... Click here if you are not automatically redirected after 5 seconds.

Related documents

• Discovery and Validation of Biomarkers for CSA-AKI Risk Prediction#825433
• Predictive Value of Risk Scores in Acute Coronary Syndrome#898573
• A machine learning model for early risk stratification of 28-day mortality after myocardial infarction / Pierre G. Aublin, Stephanie G. Kühne, David Füller, Benjamin Sasko, Hannah Schulze, Oliver Ritter, Ferdinand Bauke, Christine Meisinger, Jakob Linseisen, Philip Raake, Sebastian Zaunseder, Timo Schmitz, Dario Bongiovanni#783988
• Predictive Value of suPAR and hsCRP on Postoperative Mortality in Cardiac Surgery#874181
• Biomarkers: monoclonal protein and indicators of cardiac damage.#185590